Literature DB >> 2553817

Analysis of foot-and-mouth disease virus-neutralizing idiotypes from immune bovine and swine with anti-murine idiotype antibody probes.

A E Garmendia1, M V Borca, D O Morgan, B Baxt.   

Abstract

Rabbit anti-idiotypic antibodies (a-IdAb) induced by foot-and-mouth disease virus (FMDV) neutralizing mAb were used as probes to identify anti-FMDV Id in immune serum from bovine and swine. In a competitive RIA, at least two of the a-IdAb exhibited a dose-dependent capacity to compete with labeled virus for anti-FMDV antibodies from a convalescent bovine serum. These a-IdAb were immobilized on activated Sepharose and used to isolate anti-viral Id from bovine, swine, and murine FMDV immune sera. Both the bovine and swine antibodies recovered from the a-IdAb/Sepharose columns reacted with virus, and to a lesser extent with corresponding mAb-resistant virus variants. The binding of affinity isolated bovine and swine antibodies to virus was specifically inhibited by the homologous a-IdAb, and in addition, both were capable of neutralizing FMDV in suckling mouse protection and plaque reduction neutralization assays. Therefore, by means of a-IdAb probes generated against FMDV murine Id, two neutralizing Id were identified in bovine and swine. These results suggest that FMDV-neutralizing epitopes recognized by murine systems play a role in the overall immunity of foot-and-mouth disease-susceptible animals.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553817

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  A comparison of methods for measuring the antibody response in mice and cattle following vaccination against foot and mouth disease.

Authors:  M J Dus Santos; A Wigdorovitz; E Maradei; O Periolo; E Smitsaart; M V Borca; A M Sadir
Journal:  Vet Res Commun       Date:  2000-05       Impact factor: 2.459

2.  Cross-reactive idiotopes among anti-foot and mouth disease virus neutralizing antibodies.

Authors:  M V Borca; A E Garmendia; B Baxt; D M Moore; S Srikumaran; D O Morgan
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.